NeuroSense Therapeutics Ltd. Ordinary Shares (NASDAQ: NRSN) last traded at $0.376, up 7.39% on the session. The quote above updates while this page is open; the figures below are drawn from NeuroSense Therapeutics Ltd. Ordinary Shares’s own filings and are restated only when a new one is published.
NeuroSense Therapeutics Ltd. Ordinary Shares (NRSN) company overview
NeuroSense Therapeutics Ltd. Ordinary Shares trades on NASDAQ under the ticker NRSN. Its market capitalisation is $12.25 million.
NRSN valuation
Valuation measures for NeuroSense Therapeutics Ltd. Ordinary Shares, derived from the latest quote and its most recent SEC filing.
Market cap
$12.25M
Enterprise value
$14.67M
Beta
0.99
NRSN financials
Trailing-twelve-month figures tagged in NeuroSense Therapeutics Ltd. Ordinary Shares's XBRL filings with the SEC.
NeuroSense Therapeutics Ltd. Ordinary Shares (NRSN) last traded at $0.38, up 7.39% on the session. FurlPay quotes NRSN from Yahoo Finance and stamps each figure with the exchange time it printed.
What exchange is NRSN listed on?
NeuroSense Therapeutics Ltd. Ordinary Shares is listed on NASDAQ under the ticker symbol NRSN.
What is NeuroSense Therapeutics Ltd. Ordinary Shares's market cap?
NeuroSense Therapeutics Ltd. Ordinary Shares has a market capitalisation of $12.25 million, derived from its shares outstanding as reported in its SEC filings and the latest quoted price.
What is NRSN's 52-week range?
Over the past 52 weeks NRSN has traded between $0.25 and $1.98.
Data sources
Price, range and volume — Yahoo Finance. Quotes may be delayed; each carries the exchange timestamp it printed with.
Financials and valuation — the company’s own XBRL filings with the U.S. Securities and Exchange Commission (CIK 0001875091), period ending 2025-12-31.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.